Ortho’s COVID-19 total antibody test receives CE Mark

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its COVID-19 total antibody test received CE Mark. The test offers excellent performance, with 100 percent specificity and sensitivity.

Ortho’s COVID-19 total antibody test receives CE Mark

Ortho's total antibody test detects all COVID-19 related antibodies (IgA, IgM and IgG), including IgM, which appears in the early, acute stage of infection, and helps determine the onset of a patient's immune response by monitoring all antibodies generated through disease progression. It can help health care professionals understand if a patient has been exposed to and has developed antibodies to the SARS-CoV02 virus causing COVID-19.

The test runs on Ortho's high-throughput, fully automated analyzers including its flagship VITROS® XT 7600 Integrated System, the VITROS® 3600 Immunodiagnostic System, the VITROS® 5600 Integrated System and will soon be available on VITROS® ECi/ECiQ Immunodiagnostic Systems. VITROS Systems are self-contained and do not require an external water source to run, offering labs placement flexibility.

Ortho's test runs on the widely used Ortho VITROS platform and the results will paint a vivid picture of a patient's immune response status. Clinicians will now have invaluable information that may assist them to make decisions about the propriety of a patient returning to work. This is critical information for first responders, health care professionals and other essential personnel working with affected populations."

Chockalingam Palaniappan, Ph.D., chief innovation officer, Ortho Clinical Diagnostics

Ortho plans to manufacture several million COVID-19 total antibody tests each month in Rochester, New York and Pencoed, Wales.

Questions from laboratories, healthcare providers, or government officials regarding the COVID-19 antibody test can be directed to: [email protected]

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ortho-Clinical Diagnostics, Inc.. (2020, May 13). Ortho’s COVID-19 total antibody test receives CE Mark. News-Medical. Retrieved on October 24, 2020 from https://www.news-medical.net/news/20200513/Orthoe28099s-COVID-19-total-antibody-test-receives-CE-Mark.aspx.

  • MLA

    Ortho-Clinical Diagnostics, Inc.. "Ortho’s COVID-19 total antibody test receives CE Mark". News-Medical. 24 October 2020. <https://www.news-medical.net/news/20200513/Orthoe28099s-COVID-19-total-antibody-test-receives-CE-Mark.aspx>.

  • Chicago

    Ortho-Clinical Diagnostics, Inc.. "Ortho’s COVID-19 total antibody test receives CE Mark". News-Medical. https://www.news-medical.net/news/20200513/Orthoe28099s-COVID-19-total-antibody-test-receives-CE-Mark.aspx. (accessed October 24, 2020).

  • Harvard

    Ortho-Clinical Diagnostics, Inc.. 2020. Ortho’s COVID-19 total antibody test receives CE Mark. News-Medical, viewed 24 October 2020, https://www.news-medical.net/news/20200513/Orthoe28099s-COVID-19-total-antibody-test-receives-CE-Mark.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Ortho announces new appointiments to Board of Directors